Affordable Access

deepdyve-link
Publisher Website

The Effect of Melatonin Modulation of Non-coding RNAs on Central Nervous System Disorders: An Updated Review.

Authors
  • Lu, Jianan1
  • Luo, Yujie1
  • Mei, Shuhao1
  • Fang, Yuanjian1
  • Zhang, Jianmin1
  • Chen, Sheng1
  • 1 Department of Neurosurgery, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310003, China. , (China)
Type
Published Article
Journal
Current neuropharmacology
Publication Date
Jan 01, 2021
Volume
19
Issue
1
Pages
3–23
Identifiers
DOI: 10.2174/1570159X18666200503024700
PMID: 32359338
Source
Medline
Keywords
Language
English
License
Unknown

Abstract

Melatonin is a hormone produced in and secreted by the pineal gland. Besides its role in regulating circadian rhythms, melatonin has a wide range of protective functions in the central nervous system (CNS) disorders. The mechanisms underlying this protective function are associated with the regulatory effects of melatonin on related genes and proteins. In addition to messenger ribonucleic acid (RNA) that can be translated into protein, an increasing number of non-coding RNAs in the human body are proven to participate in many diseases. This review discusses the current progress of research on the effects of melatonin modulation of non-coding RNAs (ncRNAs), including microRNA, long ncRNA, and circular RNA. The role of melatonin in regulating common pathological mechanisms through these ncRNAs is also summarized. Furthermore, the ncRNAs, currently shown to be involved in melatonin signaling in CNS diseases, are discussed. The information compiled in this review will open new avenues for future research into melatonin mechanisms and provide a further understanding of ncRNAs in the CNS. Copyright© Bentham Science Publishers; For any queries, please email at [email protected]

Report this publication

Statistics

Seen <100 times